Common Contracts
9 similar Non-Statutory Stock Option Agreement contracts by Vitro Biopharma, Inc.
VITRO DIAGNOSTICS, INC. NON-STATUTORY STOCK OPTION AGREEMENTNon-Statutory Stock Option Agreement • September 9th, 2022 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
This Non-Statutory Stock Option Agreement (the “Agreement”) is made and entered into effective the 9th day of April, 2020, between Vitro Diagnostics, Inc., (the “Company”) and Jack Zamora (“Optionee”).
VITRO BIOPHARMA, INC. NON-STATUTORY STOCK OPTION AGREEMENTNon-Statutory Stock Option Agreement • September 9th, 2022 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
This Non-Statutory Stock Option Agreement (the “Agreement”) is made and entered into effective the 1st day of August, 2021, between Vitro Biopharma, Inc., (the “Company”) and Nathan Haas (“Optionee”).
VITRO DIAGNOSTICS, INC. NON-STATUTORY STOCK OPTION AGREEMENTNon-Statutory Stock Option Agreement • September 9th, 2022 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
This Non-Statutory Stock Option Agreement (the “Agreement”) is made and entered into effective the 30th day of November, 2020, between Vitro Diagnostics, Inc., (the “Company”) and James R. Musick (“Optionee”).
VITRO BIOPHARMA, INC. NON-STATUTORY STOCK OPTION AGREEMENTNon-Statutory Stock Option Agreement • September 9th, 2022 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
This Non-Statutory Stock Option Agreement (the “Agreement”) is made and entered into effective October 1st 2021, between Vitro Biopharma, Inc., (the “Company”) and Caroline Mosessian (“Optionee”).
VITRO DIAGNOSTICS, INC. NON-STATUTORY STOCK OPTION AGREEMENTNon-Statutory Stock Option Agreement • September 9th, 2022 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
This Non-Statutory Stock Option Agreement (the “Agreement”) is made and entered into effective the 30th day of November, 2020, between Vitro Diagnostics, Inc., (the “Company”) and John R. Evans (“Optionee”).
VITRO DIAGNOSTICS, INC. NON-STATUTORY STOCK OPTION AGREEMENTNon-Statutory Stock Option Agreement • September 9th, 2022 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
This Non-Statutory Stock Option Agreement (the “Agreement”) is made and entered into effective February 1st 2021, between Vitro Diagnostics, Inc., (the “Company”) and Caroline Mosessian (“Optionee”).
VITRO BIOPHARMA, INC. NON-STATUTORY STOCK OPTION AGREEMENTNon-Statutory Stock Option Agreement • September 9th, 2022 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
This Non-Statutory Stock Option Agreement (the “Agreement”) is made and entered into effective the 1st day of October, 2021, between Vitro Biopharma, Inc., (the “Company”) and John R. Evans (“Optionee”).
VITRO DIAGNOSTICS, INC. NON-STATUTORY STOCK OPTION AGREEMENTNon-Statutory Stock Option Agreement • September 9th, 2022 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
This Non-Statutory Stock Option Agreement (the “Agreement”) is made and entered into effective the 1st day of December 2020, between Vitro Diagnostics, Inc., (the “Company”) and Jack Zamora (“Optionee”).
VITRO BIOPHARMA, INC. NON-STATUTORY STOCK OPTION AGREEMENTNon-Statutory Stock Option Agreement • September 9th, 2022 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
This Non-Statutory Stock Option Agreement (the “Agreement”) is made and entered into effective the 1st day of October, 2021, between Vitro Biopharma, Inc., (the “Company”) and Nathan Haas (“Optionee”).
